David S. Baldwin
← Back to University of Cape Town
University of Cape Town
David S. Baldwin works in Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Treatment of Major Depression, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Schizophrenia research and treatment. Recorded institutional associations include South African Medical Research Council, University of Cape Town, Isle of Wight NHS Trust.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
2014 · 674 citationsBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
2010 · 635 citationsEvidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
2005 · 610 citationsSocial Functioning in Depression
2000 · 582 citationsGeneralised anxiety disorder
2006 · 399 citationsBiological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
2016 · 346 citationsRenal Failure and Interstitial Nephritis Due to Penicillin and Methicillin
1968 · 340 citationsVeterinary surgeons and suicide: a structured review of possible influences on increased risk
2010 · 324 citationsAntidepressants and their effect on sleep
2005 · 314 citationsBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
2019 · 312 citationsLupus nephritis
1977 · 300 citationsEfficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
2011 · 285 citationsBritish Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
2017 · 271 citationsParoxetine in social phobia/social anxiety disorder
1999 · 251 citationsSelective Serotonin Reuptake Inhibitor-Induced Serotonin Syndrome
1997 · 247 citationsBenzodiazepines: Risks and benefits. A reconsideration
2013 · 246 citationsEvidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology
2023 · 246 citationsEscitalopram Therapy for Major Depression and Anxiety Disorders
2007 · 228 citationsTreatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release
2006 · 228 citationsTranscranial direct current stimulation (tDCS) in the treatment of depression: Systematic review and meta-analysis of efficacy and tolerability
2015 · 219 citationsDepression and sexual dysfunction
2001 · 217 citationsWhat Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?
2006 · 203 citationsAntidepressants for insomnia in adults
2018 · 198 citationsThe impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management
2018 · 189 citationsPeripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study
2017 · 188 citations
